VULVAL CANCER STAGE I

This adverse event was reported 16 times

VULVAL CANCER STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TISOTUMAB VEDOTIN 1 0.0010
1 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 2 0.0002
2 NAPROXEN SODIUM 220MG 2 0.0001
3 OCTREOTIDE ACETATE 3 0.0001
4 CICLESONIDE 1 0.0001
5 IBUPROFEN SODIUM 2 0.0000
6 MEPOLIZUMAB 2 0.0000
7 CYANOCOBALAMIN 1 0.0000
8 SODIUM CHLORIDE TABLET 2 0.0000
9 SODIUM CHLORIDE TABLETS 2 0.0000
See all drugs enriched for association with VULVAL CANCER STAGE I

VULVAL CANCER STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 2 0.0029
1 Integrin Receptor Antagonist [EPC] 1 0.0000
2 Parathyroid Hormone Analog [EPC] 1 0.0000
3 Osmotic Laxative [EPC] 2 0.0000
4 Calcium [EPC] 1 0.0000
5 Vitamin B12 [EPC] 2 0.0000
6 Interferon beta [EPC] 1 0.0000
7 Vitamin D [EPC] 1 0.0000
8 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
9 Vitamin C [EPC] 1 0.0000
See all drug classes enriched for association with VULVAL CANCER STAGE I